PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient
PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient Source link...
Tag: hypercholesterolemia
Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them
Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them Source link...
Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia
AbstractBackground Lipoprotein(a) is an atherogenic low-density lipoprotein–like particle and circulating levels are largely determined by genetics. Patients with familial hypercholesterolemia (FH) have elevated lipoprotein(a); however,...
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans Source link...
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects
AbstractBackground Despite the greater prevalence of familial hypercholesterolemia (FH) in subjects with ischemic heart disease (IHD), premature IHD, and severe hypercholesterolemia (low-density lipoprotein ≥190 mg/dl), overall prevalence...
Molecular diagnosis methods in familial hypercholesterolemia.
Related Articles Molecular diagnosis methods in familial hypercholesterolemia. Anatol J Cardiol. 2020 Feb;23(3):120-127 Authors: Moldovan V, Banescu C, Dobreanu M Abstract Familial hypercholesterolemia (FH) is...
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
AbstractBackground Proprotein convertase subtilisin/kexin type 9 inhibitor therapy is a treatment option for patients with familial hypercholesterolemia (FH) who are unable to reach low-density lipoprotein...
Aggressive Treatment for Severe Forms of Familial Hypercholesterolemia
Aggressive Treatment for Severe Forms of Familial Hypercholesterolemia Source link...
Statin Use in Children With Familial Hypercholesterolemia
Statin Use in Children With Familial Hypercholesterolemia Source link...
Public Policy Recs Updated for Familial Hypercholesterolemia
Goals include enhancing awareness of familial hypercholesterolemia as a global public health issue Source link...
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.
Related Articles Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia. Atherosclerosis. 2019 Nov 29;292:143-151 Authors: Lamiquiz-Moneo I, Restrepo-Córdoba MA, Mateo-Gallego...
Reply: Familial Hypercholesterolemia Causes Sudden Death
Reply: Familial Hypercholesterolemia Causes Sudden Death Source link...
Familial Hypercholesterolemia Causes Sudden Death
Familial Hypercholesterolemia Causes Sudden Death Source link...
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
AbstractBackground Evolocumab and other anti-PCSK9 antibodies reduced adverse cardiovascular outcomes in clinical trials of high-risk patients over <3 years median treatment duration. Objectives The OSLER-1 trial...
Prevalence of hypercholesterolemia in Nigeria: a systematic review and meta-analysis.
Related Articles Prevalence of hypercholesterolemia in Nigeria: a systematic review and meta-analysis. Public Health. 2019 Nov 04;178:167-178 Authors: Adeloye D, Abaa DQ, Owolabi EO, Ale...
Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism
Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism Source link...
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 Years
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 Years Source link...
Long-Term Benefit of Early Statin Therapy for Familial Hypercholesterolemia
Improved low-density lipoprotein levels and reduced cardiovascular event risk were shown after 20 years of statin treatment in children with FH. Source link...
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Related Articles Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. Atherosclerosis. 2019 Aug...